Explore 3 Stock Ideas & Industry Insights Download Free Report
Bioventix Plc recorded a6.67%gain on 24 July 2026 as investors increased exposure to specialist healthcare and biotechnology companies benefiting from expanding global demand for advanced diagnostic solutions.
CellXxHealth plc gained5.88%on24 July 2026as investors increased exposure to healthcare companies focused on innovative medical technologies and next-generation treatment solutions.
LSE:FUM – Futura Medical plcattracted significant attention after its shares fell20.23%during trading on24 July 2026. The sharp decline placed the company among the session's weakest performers and generated strong interest from retail and institutional investors monitoring UK healthcare and biotechnology stocks.
hVIVO plc advanced6.42%on24 July 2026as investors increased exposure to specialist healthcare companies benefiting from continued growth across the pharmaceutical and biotechnology industries.
Companies in the pharmaceuticals space are typically valued using metrics relevant to their business model and sector peers.
Companies in the pharmaceuticals space are typically valued using metrics relevant to their business model and sector peers.
Scancell Holdings Plc is a late-stage clinical immuno-oncology company developing active cancer immunotherapies designed to stimulate the immune system against difficult-to-treat cancers. The company generates value through clinical development, strategic partnerships and potential future commercialisation rather than recurring product revenues. Despite announcing transformational strategic …
Proteome Sciences plc (LSE:PRM) attracted significant investor attention after its shares declined7.47%during trading on23 July 2026, placing the company among the largest fallers within the UK healthcare sector.
Thalia Therapeutics PLC (LSE:THAT) came under the spotlight after its shares declined7.14%during trading on23 July 2026, placing the company among the day's largest healthcare sector decliners.
Fusion Antibodies plc (LSE:FAB) attracted investor attention after its shares declined6.05%during trading on23 July 2026.
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…